| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Denosumab in cancer patients with bone metastases
|
Abraham, Jame
|
|
2011
|
8 |
2 |
p. 59-61
3 p.
|
artikel
|
| 2 |
First-line treatment of chronic myeloid leukemia: imatinib versus nilotinib and dasatinib
|
DiBella, Nicholas J.
|
|
2011
|
8 |
2 |
p. 65-72
8 p.
|
artikel
|
| 3 |
Ixabepilone in advanced breast cancer: clinical, treatment, and cost-related studies
|
Brufsky, Adam
|
|
2011
|
8 |
2 |
p. 73-80
8 p.
|
artikel
|
| 4 |
Management of capecitabine-related gastrointestinal toxicities in women with breast cancer
|
Bayraktar, Soley
|
|
2011
|
8 |
2 |
p. 81-87
7 p.
|
artikel
|
| 5 |
New antiresorptive agents in metastatic breast cancer: an advance or more of the same?
|
Brufsky, Adam
|
|
2011
|
8 |
2 |
p. 61-62
2 p.
|
artikel
|
| 6 |
One transition at a time, please
|
London, Susan
|
|
2011
|
8 |
2 |
p. 92-
1 p.
|
artikel
|
| 7 |
Radiation overexposure following brain perfusion CT scans in California, Florida, and Alabama (2008–2009)
|
Qureshi, Zaina P.
|
|
2011
|
8 |
2 |
p. 89-91
3 p.
|
artikel
|
| 8 |
The FDA's Avastin decision flies in the face of science-based medicine
|
Schwartzberg, Lee S.
|
|
2011
|
8 |
2 |
p. 57-
1 p.
|
artikel
|
Tijdschrift beschrijving